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Unlike the heterodimeric poly(A) polymerase (PAP) of vaccinia virus (VACV), the PAP from the Amsacta moorei entomopoxvirus, AMEV, is
potentially derived from three subunits: a single large and two small subunits (AMV060 and AMV115). The VACV small subunit serves as a 2′-O-
methyltransferase, a processivity factor for mRNA polyadenylation, and a transcription elongation factor. We wished to determine the structure–
function relationships of the three putative AMEV PAP subunits. We show that AMV060 is expressed as an early gene persisting throughout
infection, whereas AMV115 is expressed late.We demonstrate that AMV060 exhibits 2′-O-methyltransferase activity but the gene is not essential for
virus growth. Absence of the AMV060 protein has no effect on the length of the poly(A) tails present in mRNA. No physical association was found
between any of the putative AMEV PAP subunits. We therefore propose that mRNA polyadenylation does not require interactions between these
three proteins.
© 2008 Elsevier Inc. All rights reserved.Keywords: Entomopoxvirus; Poly(A) polymerase; Methyltransferase; PoxvirusIntroduction
The entomopoxvirus isolated from the larvae of the moth,
Amsacta moorei, (AMEV, formerly AmEPV) (Buller et al.,
2005; Roberts and Granados, 1968) is a distant relative of the
better studied orthopoxviruses which include variola and
vaccinia virus (VACV). AMEV is the only entomopoxvirus
that can be readily grown and manipulated in tissue culture.
Although many similarities exist between both the life cycle
and gene complement of the orthopoxviruses and entomo-
poxviruses, there are some significant differences between
them such as a lack of a conserved “core gene order”, and
generally discrete 3′ termini of late mRNA in AMEV (Bawden
et al., 2000; Becker and Moyer, 2007; Buller et al., 2005;⁎ Corresponding authors. Molecular Genetics and Microbiology, PO Box
100266, University of Florida, Gainesville, FL 32610, USA. Fax: +1 352 392
3133.
E-mail address: mnbecker@ufl.edu (M.N. Becker).
0042-6822/$ - see front matter © 2008 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2008.02.023Gubser et al., 2004; Upton et al., 2003). Another potential and
intriguing difference is reflected in the virus encoded poly(A)
polymerase (PAP) holoenzyme. The orthopoxvirus (VACV)
enzyme is a heterodimer consisting of a large and small sub-
unit. In the case of AMEV, there are potentially two small
subunits (AMV060 and AMV115) as opposed to the single
small subunit encoded by the VACV J3R gene. Both putative
AMEV proteins have sequence similarity to the J3 small sub-
unit of the VACV PAP heterodimer (Gershon et al., 1991).
Like VACV, the AMEV genome encodes a single large sub-
unit, AMV038. The unexpected finding of two putative small
PAP subunits led us to explore the role of each of these proteins
in poly(A) addition to mRNA and the virus life cycle.
The VACV J3R gene encodes a 39 kDa protein known as J3
or VP39. J3 was originally isolated as a 2′-O-methyltransferase
but was later discovered to also comprise the smaller subunit of
the heterodimeric PAP where the large subunit of the PAP is
encoded by E1L (Barbosa andMoss, 1978; Gershon et al., 1991;
Schnierle et al., 1992). J3 is synthesized in excess and is present
within the VACV virion both as a component of the heterodimer
Table 1
Percent amino acid similarity between J3 orthologs
VACV J3 MSEV041 HaEPV DlEPV
AMV060 54.76% 56.01% 82.07% 62.11%
AMV115 42.23% 53.85% 50% 48.66%
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and by more recent mass spectrometry analysis of the com-
position of the purified VACV virion (Barbosa and Moss, 1978;
Chung et al., 2006; Gershon and Moss, 1992; Moss et al., 1975;
Resch et al., 2007; Yoder et al., 2006).
The J3 protein is multifunctional, acting at the 5′ end of the
mRNA as a 2′-O-methyltransferase to convert the cap 0 structure
to a cap 1 structure and at the 3′ end of the mRNA as part of the
E1/J3 heterodimer to polyadenylate the mRNA. In 3′ poly(A)
formation, J3 functions as a processivity factor for the E1 protein
which alone can only add 30–35 adenylate residues to the 3′ end
of mRNA before significantly slowing its rate of addition
(Gershon and Moss, 1992). In contrast, the E1/J3 heterodimer
catalyzes the addition of a poly(A) tail several hundred nu-
cleotides in length due to the processive action of the J3 subunit
(Gershon et al., 1991; Schnierle et al., 1992). Yet another role for
J3 has been described, that of a transcription elongation factor.
Null mutants of J3 are defective in transcription elongation and
are dependent upon the drug IBT for growth (Latner et al., 2000).
The viability of these null mutants and their dependence on IBT
for growth implies that the polyadenylation stimulatory activity
and the methyltransferase activity provided by J3 are not
essential. All three functions of J3 are genetically separable and
independent of each other (Gershon et al., 1998; Latner et al.,
2002). Several crystal structures of J3 have been determined
(Hodel et al., 1996). Recently, the crystal structure of the E1/J3
heterodimer was solved (Moure et al., 2006).
The multifunctional nature of J3 and the presence of two
putative small PAP subunits in AMEV lead to the intriguing
question of why there are potentially two small subunits, whether
either participates in polyadenylation and whether the multiple
activities assigned to J3 might be partitioned between the two
AMEV subunits or perhaps developmentally regulated. To date,
AMEVis the only poxvirus reported to encode two putative small
PAP subunits. The other fully sequenced entomopoxvirus from
the grasshopper,Melanoplus sanguinipes, (MSEV) contains only
one J3 ortholog (Afonso et al., 1999). The sequences of two other
entomopoxvirus PAP small subunits are recorded in Genbank,
one from themoth,Heliothis armigera (AF022176) and one from
a parasitic wasp, Diachasmimorpha longicaudata (AY598432)
(Crnov and Dall, 1999; Hashimoto and Lawrence, 2005). Neither
virus has been fully sequenced, so the presence of a second
subunit cannot be ruled out. In order to address the question of
how themultiple functions of J3 are supplied in AMEV, we began
an investigation of the AMEV poly(A) polymerase and asked
whether one or both of the small subunits interact with the large
subunit to form a heterodimer or possibly a trimer. We have also
assayed poly(A) tail length, performed methyltransferase assays,
examined the temporal expression of each subunit and whether
the small subunits are essential for growth.
Results
Sequence comparisons
Although neither AMV060 nor AMV115 is highly homo-
logous to the respective orthopoxvirus small poly(A) polymer-ase subunits, they are sufficiently similar to be identified as
small PAP subunits via BLAST searches. Table 1 indicates the
percent amino acid similarity between the two AMEV subunits,
the VACV subunit (J3), and the entomopoxvirus small subunit
from MSEV (MSEV041), H. armigera EPV and D. long-
icaudata EPV (http://www.poxvirus.org). Based on this analy-
sis, AMV060 is more similar to both VACV J3 and the
predicted proteins from the three other entomopoxvirus se-
quences available in Genbank than is AMV115. A number of
residues critical for the different VACV J3 functions have been
identified and are indicated in Fig. 1. These include the K41,
R140, K175 and R209 residues required for methyltransferase
activity; Y22 and F180 for cap binding; and G68, G72, D95,
V116 and D138 for S'adenosyl methionine (SAM) binding (all
numbering is based on the VACV J3 protein) (Hodel et al.,
1996; Shi et al., 1996). A closer examination of the protein
sequence predicted for AMV060 reveals that all of these critical
residues are conserved with the exception of V116. This would
lead us to hypothesize that AMV060 protein would be able to
both bind the mRNA cap and function as a 2′-O-methyltrans-
ferase. However, alignments of the AMV115 predicted protein
with VACV J3 indicate that both the Y22 and F180 residues
required for binding the RNA cap are missing, and only the
catalytic K175 and R209 residues are conserved among the
residues important for methyltransferase activity. Furthermore,
two residues involved in SAM binding, G72 and V116, are also
missing. This would seem to indicate that AMV115 protein
cannot bind the mRNA cap and is probably not capable of 2′-O-
methyltransferase activity. The residues implicated for binding
between the E1 and J3 subunits of the heterodimer are not well
conserved in either AMEV subunit. (Moure et al., 2006).
Expression and purification of AMV060 and methyltransferase
assays
Soluble His-tagged AMV060 protein was readily expressed
in Escherichia coli cells with the inducible T7 RNA polymerase
system (Materials and methods). The His-tagged AMV060
protein was purified via metal chelation affinity chromatography
followed by passage through a cation exchange column. The
purified protein electrophoretically migrates with an apparent
lower molecular weight than its predicted size of 39.2 kDa
(Fig. 2A). The purified protein was tested for 2′-O-methyl-
transferase activity by the ability to catalyze the addition of
methyl groups to the cap 0 structure of brome mosaic virus
genomic RNA. As indicated in Fig. 2B, the purified His-060
protein does possess a 2′-O-methyltransferase activity although
it catalyzes the reaction less efficiently than the similar reaction
with His-tagged J3 protein.
Fig. 1. Alignment of AMEVand VACV small PAP subunits. Critical amino acids with known functions in the VACV J3 subunit are designated thus: residues involved
in cap binding are indicated by ^; those necessary for SAM interactions by ⁎; and residues for methyltransferase function by ♦. Alignment constructed with AlignX
program (Invitrogen) which uses a Clustal W algorithm. Identical residues have black backgrounds. Similar residues are gray.
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His-tagged AMV115 was also produced efficiently in T7
RNA polymerase expressing E. coli, but the protein was inso-
luble. A number of modifications to the expression conditions
were investigated in order to increase the amount of soluble
protein produced, including expression in various E. coli strains
and a baculovirus expression system. We also changed the tag to
an N-terminal GST tag and modified the temperature used
during the induction period of protein expression. None of theFig. 2. Purification of His-060 protein and methyltransferase activity assay. A. Coom
cation exchange chromatography. B. Methyltransferase assay. The incorporation of 3
VACV His J3 protein indicating 2′-O-methyltransferase activity.conditions examined increased the amount of soluble protein.
However, we were able to substantially purify the His-115 pro-
tein after solubilization in guanidine hydrochloride followed by
metal chelation chromatography under denaturing conditions.
Attempts to re-fold the protein while on the column or following
elution and during subsequent dialysis did not result in soluble
protein. Thus we were unable to assess the AMV115 protein for
2′-O-methyltransferase activity.
As for the large subunit, AMV038, we have been unable to
express AMV038 to any extent under any conditions in eitherassie stained gel of His-tagged AMV060 protein purified via metal chelation and
H methyl groups into BMV genomic DNA at 37° by 2 µg of either His-060 or
Fig. 3. Deletion of the AMV060 gene in AMEV. Immunoblots developed with
either A) the chicken anti-060 antisera or B) rabbit anti-060 peptide antisera. The
results indicate an absence of the AMV060 protein from AMEVΔ060.
Arrowheads indicate the position of the AMV060 protein.
Fig. 4. Comparative growth curves for AMEV and AMEVΔ060. A) Growth
curves at low multiplicity (MOI=0.01), and B) at high multiplicity (MOI=10).
Virus yields at various time points were determined via plaque assay. Duplicate
samples were titered. Error bars indicate the standard deviation.
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difficulties with expression of AMV115 and AMV038, we have
focused the remaining studies on AMV060.
Deletion of the AMV060 gene from AMEV
One method to determine whether a gene is essential for
growth and perhaps infer function is to either delete the gene or
alternatively, place the gene under control of an inducible pro-
moter. We were readily able to delete AMV060 from the virus via
gene displacement using a plasmid containing 5′- and 3′-terminal
AMV060 flanks betweenwhich was inserted aGFPmarker under
the control of the spheroidin promoter. GFP expressing plaques
were readily isolated and extracts from infected cells examined
via Western blot analysis for expression of the AMV060 protein.
Absence of the AMV060 protein in AMEVΔ060 infected cells
was confirmed by both the chicken antisera against His-AMV060
and the rabbit anti-AMV060 peptide antibody (Fig. 3).
We have also examined the growth properties of AMEVΔ060
virus. The virus replicates and spreads as well as wild-type virus
in cell culture following low multiplicity infection (Fig. 4A).
Furthermore, the yield of virus per cell is equivalent to that of
wild-type virus as indicated by one-step growth curves (Fig. 4B).
In summary, the behavior of AMEVΔ060 in cell culture is
undistinguishable from that of wild-type virus.
It was somewhat surprising to find that AMV060 is a non-
essential gene, although VACV viruses that are deficient in either
methyltransferase activity or poly(A) processivity due to muta-
tions in VACV J3 are viable (Latner et al., 2002; Shi et al., 1997).
However, the transcription elongation function of VACV J3 is
thought to be essential since viruses deleted for the J3 gene do not
grow unless the drug IBT is present (Latner et al., 2000). By
implication, the lack of any requirement for AMV060 under
normal conditions indicates that it does not possess a transcription
elongation activity that is required for growth or that activity is
redundant with that of another gene.
We have repeatedly attempted to delete AMV115 from the
genome in a similar fashion using a variety of strategies but
were unsuccessful. This result implies that in contrast to
AMV060, AMV115 is an essential gene.AMEV mRNA poly(A) tail length in the presence and absence
of AMV060
In order to test the hypothesis that the AMV060 protein may
participate as a non-essential processivity factor for the addition
of poly(A) catalyzed by the AMV038 large protein subunit, we
analyzed the length of poly(A) tails present on mRNA isolated
from WT AMEV and AMEVΔ060 infected cells. For com-
parison, the length of poly(A) tails from mRNA isolated from
VACV infected cells was also analyzed.
Previous VACV studies indicated that in the absence of J3
protein, poly(A) tails were significantly shorter in length than
wild-type virus tails (Latner et al., 2000; Xiang et al., 2000). A
length analysis of the poly(A) tails is presented in Fig. 5. A
comparison of the length of poly(A) tails found in WT AMEV
infected cells (Fig. 5B) with those found in WT VACV cells
(Fig. 5E) reveals that tail length in AMEV transcripts is intrin-
sically shorter than the corresponding tails in VACV. In fact, the
length profile of AMEV tails resembles that of the J3 deficient
virus (Fig. 5F) in which poly(A) tails are shorter than those
found for WT VACV. The length of poly(A) tails produced in
Fig. 5. Analysis of poly(A) tail length. The length of poly(A) tails on mRNAwas analyzed from total RNA harvested from cells infected at an MOI=10 at 18 hpi. After
radiolabeling and RNase digestion, the poly(A) tails which remain were analyzed on a polyacrylamide sequencing gel and visualized on a phosphorimager screen. The
length of the poly(A) tails was measured with a Storm phosphorimager and the resultant graphs presented here. The intensity of the bands is graphed in arbitrary units
on the ordinate and the scale varies for each sample. The size in bases is graphed on the abscissa decreasing from left to right. RNA from each of the following
conditions is shown: A. uninfected Ld652 cells; B. wild-type AMEV infected Ld652 cells; and C. AMEVΔ060 infected Ld652 cells. Bottom row: D. uninfected
BSC40 cells; E. wild-type VACV infected BSC40 cells and F. mutant VACV J3-7 infected BSC40 cells.
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produced by WT AMEV, suggesting that AMV060 plays no
role in poly(A) tail length. The intrinsically shorter length of
wild-type AMEV tails compared with VACV tails also implies
that the AMEV shorter poly(A) tails may be sufficient and that
no further addition of poly(A) is required over that provided by
the AMEV large subunit itself.
Temporal expression of AMV060, AMV115 and AMV038
One possible way to distinguish between the roles and
functional redundancy of the two small subunits is to examine
their temporal expression. Predictions about the temporal class
of each gene can be made from an analysis of the DNA
sequence at both the 5′ and 3′ termini of the gene. Bawden et al.
predicted that AMV060 would be expressed both at early and
late times after infection, whereas AMV115 and AMV038 were
both predicted to be expressed only late in infection (Bawden
et al., 2000). The VACV J3 small subunit is expressed early and
predicted to be expressed late during infection as well, since J3
is packaged in the virion (Barbosa and Moss, 1978; Plucien-
niczak et al., 1985). The large VACV subunit, E1, is also
thought to be expressed both early and late (Ed Niles, personal
communication; http://www.poxvirus.org/vaccinia_orthologs.
asp). Fig. 6A shows extracts of AMEV infected cells probed
with the rabbit anti-060 peptide antisera at various times afterinfection. When compared with the immunoblot in Fig. 6B
which is probed with the chicken anti-060 antisera, we can see
that the rabbit peptide antisera is somewhat less sensitive, al-
though more selective, than the corresponding antisera pro-
duced in chickens against the entire protein as antigen. The
rabbit antibody detects AMV060 protein faintly at 9 and 12 hpi
with increasing intensity of the band from 18–24 hpi. The blot
probed with the more sensitive chicken antisera (Fig. 6B),
indicates that the AMV060 protein is present early during
infection (3 hpi) and increases throughout the course of in-
fection. Early expression is confirmed by a mouse polyclonal
serum indicating that AMV060 is present at all time points
assayed including 6 hpi (Fig. 6C). Thus, the AMV060 protein
appears to be first expressed early and persists throughout
infection in a fashion similar to VACV J3.
In contrast to AMV060 protein, AMV115 protein appears to
be found beginning at 12 hpi and later with the bulk of the
expression occurring between 18–24 hpi (Fig. 7A) suggesting
that unlike AMV060, AMV115 is a late protein. Further evidence
to support this conclusion is provided by an AMV115 Northern
blot analysis, shown in Fig. 7C. The transcript for AMV115 is
clearly seen as a single band of approximately 1.2 kb visible only
late during infection (Fig. 7C). The AMV115 orf is 882 bp in
length. For comparison, Northern blots of the early gene thymi-
dine kinase, tk (Fig. 7D) and the late gene p4a (Fig. 7E) are
shown. The transcription profile of AMV115 is consistent with
Fig. 6. Time course of AMV060 protein expression. Protein samples were
harvested after infection at the times indicated and analyzed on immunoblots
with the following antibodies: A. rabbit anti-060 peptide antibody; B. chicken
anti-060 antibody; and C. polyclonal mouse anti-060 antibody. Arrows indicate
wild-type 060, mock infected cells are denoted as M, and purified His-060
protein is so designated. The His-060 protein migrates slower than the wild-type
protein due to the presence of the His tag. In all blots, M represents mock
infected cells.
Fig. 7. Time course of AMV115 expression. A. Immunoblot with rabbit anti-115
peptide antibody. Protein samples were harvested at the times indicated. M
indicates mock infected cells. Partially purified His-115 is shown as a control.
The addition of the His tag appears to lead to a slight retardation in the mobility
of the protein compared to the untagged protein. B. Blots containing 0.5 µg each
of purified His-060 and His-115 protein detected with either rabbit anti-060 or
anti-115 peptide antibodies indicate no cross reactions by these antibodies to the
other protein. C. Northern blot probed with an antisense oligonucleotide to
AMV115. The RNA samples were harvested from infected Ld652 cells at the
times indicated and each lane contains 3 μg total RNA. Blots probed with
antisense oligonucleotides for either the D. early (tk) and E. late (p4a) genes are
shown below (tk and p4a blots taken from Becker et al., 2004).
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protein. Therefore, the expression kinetics of the two putative
small PAP subunits are quite distinct.
Finally, we examined themRNAprofile for the largeAMV038
subunit. Repeated blots indicate that the pattern of expression of
theAMV038 gene is complex. There appear to be twomain bands
present on this blot indicated by the arrows in Fig. 8A. The larger,
somewhat diffuse RNA band is approximately 4.8 kb and the
smaller band is 1.5 kb. The gene upstream of AMV038 is tran-
scribed in the opposite orientation of AMV038 thus read through
transcription does not provide a simple explanation for the two
bands. Both visible bands must include the AMV038 gene,
although the smaller band is of insufficient length to account for a
complete AMV038 orf (1.722 kb) perhaps indicating an early
termination or an alternative transcription start site. Both bands
have a similar temporal expression pattern first appearing weakly
at 6 hpi and exhibiting an increase in intensity at 9 hpi and
remaining visible throughout the time course.
AraC is commonly used as a poxvirus DNA synthesis inhi-
bitor and has been used to help identify early genes which are
synthesized prior to DNA synthesis. Intermediate and late genes
require DNA replication and therefore they are not expressed in
the presence of AraC. AraC appears to have little effect on
AMV038 transcription. As seen in Fig. 8C, the late gene p4a, is
not completely inhibited by AraC, but rather exhibits a some-
what delayed expression. This is also true of the expression ofGFP under the control of the very late spheroidin promoter as
examined microscopically (data not shown). Earlier results
suggested that AraC is effective in insect cells (Winter et al.,
1995) but under our improved growth conditions the AraC
appears to be metabolized resulting in a transient effect despite
initial concentrations greater than five times that used for
VACV. The early tk gene transcript appears to persist for a
Fig. 8. Northern analysis of AMV038 expression in cells infected in the presence or absence of AraC. All blots contain 3 µg of total RNA per lane. RNAwas harvested
from Ld652 infected with WTAMEVat the time points indicated. A. RNA probed with an AMV038 riboprobe. The left portion of the blot shows AMV038 profile in
the absence of AraC. The right portion is RNA harvested from infected cells grown in the presence of 250 μg/ml AraC. Control Northern blots for B. the early gene, tk,
and C. the late gene, p4a for comparative purposes.
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Expression of the larger AMV038 transcript is delayed in the
presence of AraC indicating similar characteristics to that of a
known late gene (p4a). The 1.5 kb AMV038 RNA pattern,
although complex appears little if at all affected by AraC similar
to that of an early gene. Hence, AMV038 might be considered
an early/late gene since the 4.8 kb band is clearly present at an
earlier time than that seen for the expression of p4a. It is clear
that AraC does not clearly delineate early and late genes in
AMEV, allowing only a delay in DNA synthesis and may be
metabolized by the insect cells resulting in release of inhibition.
Analysis of large and small protein subunit interactions
The fact that AMEV poly(A) tails are short compared to
those of VACV but similar in length to VACV J3 mutants and is
unaltered whether AMV060 is present or not, raises the question
of whether the AMEV poly(A) polymerase large subunit
physically interacts with either of the small subunits. We have
addressed this question in two ways. Both methods first involve
expressing the different protein subunits under the control of a
T7 RNA polymerase promoter in a T7 RNA polymerase ex-
pressing cell line, BSR-T7. Each PAP subunit was cloned prior
to expression in such a way that an epitope tag was expressed ateither the amino or carboxy terminus of the protein. An in-
fluenza HA tag was placed at the amino terminus or alter-
natively, a FLAG tag was placed at the carboxy terminus of each
protein. Positive controls for interactions between AMEV large
and small subunits were provided by the VACV poly(A) poly-
merase subunits E1 and J3 expressed under the same conditions.
Interactions were examined by either co-immunoprecipitation
with antibodies to the expressed tags or by a bead based Am-
plified Luminescent Proximity Homogeneous Assay (AlphaSc-
reen, Perkin Elmer).
The results found using a co-immunoprecipitation assay are
presented in Fig. 9. We first note that the N- or C-terminal
location of the epitope tags on the VACV J3 and E1 control
proteins markedly influences the ability of the proteins to inter-
act (Fig. 9A, lanes 1–6). Co-precipitation indicative of subunit
interaction between J3 and E1 is clearly detectable when E1 is
tagged with HA at the amino terminus and J3 is tagged with
FLAG at the carboxy terminus (Fig. 9A, lanes 2 and 3). How-
ever, when E1 is tagged at the carboxy terminus end with
FLAG, and J3 tagged at the N-terminus with HA, no interaction
is found between E1 and J3 (lanes 5 and 6). We have not
investigated whether this reflects the location of the tag, the
nature of the tag or which of the two proteins or both is re-
sponsible for the lack of detectable interaction.
Fig. 9. Co-immunoprecipitations of poly(A) polymerase subunits. Radiolabeled protein extracts were derived from BSR-T7 cells that were transfected with plasmids
which express the epitope-tagged PAP subunits. Extracts were incubated with the indicated antibody and then immunoprecipitated with protein A sepharose.
Precipitated proteins were visualized by autoradiography after SDS-PAGE. A. Examination of interactions between VACV subunits E1 and J3 subunits.
B. Examination of interactions between FLAG tagged individual small AMEV subunits and the HA tagged large subunit. AMV115 FLAG appears to be expressed as a
doublet, lanes 9 and 15. C. Examination of interactions between HA tagged individual small AMEV subunits and the FLAG tagged large subunit. D. Examination of
potential interactions between the two small subunits or all three AMEV PAP subunits. The double arrow for 060 indicates the small difference in size between HA-060
and 060-FLAG.
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subunit and either of the two small subunits were negative
(Fig. 9B and C). Whether the large subunit was HA tagged and
the small subunits N-terminal FLAG tagged (Fig. 9B) or vice
versa (Fig. 9C) made no difference. Furthermore the presence of
all 3 proteins together failed to generate any detectable inter-
actions (Fig. 9D, lanes 27 and 28). The two small subunits also
do not appear to interact (Fig. 9D, lanes 29 and 30). In summary,
in contrast to the VACV enzyme, no interactions between PAP
large and small subunits were detected via immunoprecipitation
analysis.
We also explored potential subunit interactions by Alpha
Screen technology. This sensitive method makes use of donor
and acceptor beads coupled to antibodies against the epitopes of
tagged proteins in order to detect protein–protein interactions in
cell extracts. Upon proximity of the donor bead to the acceptor
bead and excitation of the donor bead, energy is transmitted
from the donor bead to the acceptor bead resulting in the emis-
sion of light which is then quantified. Fig. 10 shows the resultsof two such experiments. We first confirmed the interaction of
VACV J3-FLAG and HA-E1 and the lack of interaction
between the “reverse tagged” HA-J3 and E1-FLAG (Fig. 10A).
The remaining portion of Fig. 10A presents the data for
the AMV038-FLAG subunit and HA tagged small subunits.
Panel B graphs the data for potential interactions of HA-038
with the FLAG tagged small subunits. The final two bars in
Fig. 10B indicate no interaction between the two small subunits.
In complete agreement with our immunoprecipitation experi-
ments, we again see no evidence of an interaction between any
of the AMEV subunits nor could we show any indication of
interactions between any of the AMEV and VACV subunits
(data not shown).
Discussion
Our data suggest that the average mRNA poly(A) length and
the mechanism of addition of poly(A) in AMEV are drama-
tically different than for VACV. AMEV produces mRNA with
Fig. 10. Alpha Screen analysis of potential protein–protein interactions. Protein extracts were made from BSR-T7 cells that were transfected overnight with plasmids
designed to express epitope-tagged proteins under control of a bacteriophage T7 promoter. Biotinylated anti-HA antibody, streptavidin donor beads and anti-FLAG
receptor beads were incubated with the extracts and light emission was quantified with an EnVision plate reader. Levels of light emission are graphed in relative light
units (RLU). Panels A and B represent experiments performed at different times, note the different scales. n=2 for both panels and the average value is presented.
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action of the large PAP subunit alone. This difference in poly(A)
tail length is consistent with the fact that we could detect no
interactions between any AMEV PAP subunits. However, we
recognize that failure to detect interactions could be the result of
unintended artifacts arising from our method of protein ex-
pression including the epitope tags involved. A T7 RNA poly-
merase mediated expression system adapted for insect cells is
not currently available which would help to address some of
these questions. Although AMV060 encodes a functional 2′-O-
methyltransferase, the protein is not essential for virus growth.The clear implication is that either 2′-O-methylation of the
mRNA is not required or a redundant activity is provided by
another cellular or viral protein, perhaps AMV115, the second
small subunit. We have not examined the methylation state of
AMEV in vivo mRNA and do not know whether it possesses a
cap 1 structure and this is clearly a relevant question. While not
essential for virus growth in cell culture, it is quite possible that
the AMV060 protein has a role in the infection of insects which
is not revealed in vitro. Although capping of RNA provides
stability and better levels of translation, the function of the 2′O
methyl group is not well understood and it is clearly non-
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transferase activity and produces RNA with a cap 0 structure
(Latner et al., 2002).
We were somewhat surprised that despite ready deletion of
the AMV060 gene, we could not delete AMV115. Although
this is not a conclusive proof, this result suggests that AMV115
is an essential gene. Establishing a system for placing individual
AMEV genes under control of inducible promoters would allow
us to address this question in more detail. We would hypo-
thesize that if AMV115 retains any functional similarity to J3, it
might have the essential transcription elongation property.
Whether it contains 2′-O-methyltransferase activity is in doubt
based on sequence analysis indicating the absence of some
critical amino acid residues.
We were unable to address some the questions about the
function of the PAP subunits, particularly AMV115 and the
large subunit AMV038 due to the poor expression of the latter
subunit in E. coli and the insolubility of AMV115. We have
experimented with expressing both of these proteins in a ba-
culovirus system with similar negative results. Co-expression of
AMV038 with either or both of the small subunits in bacu-
lovirus vectors did not increase expression levels. In the future,
we plan to generate an AMEV designed to express a tagged
version of the AMV038 large subunit. This would facilitate
purification of the protein from AMEV infected cells for sub-
sequent studies. Whether AMV038 is essential for growth was
not explored but we would predict the gene to be essential and
would likely be solely responsible for the short 3′ poly(A) tail
we detect on AMEV mRNA. Although there is only 27% iden-
tity between VACV E1 and AMV038, the recent publication of
the E1/J3 heterodimer structure (Moure et al., 2006) might
allow the AMV038 protein to be modeled and provide clues as
to how the protein might function.
In conclusion,we propose that the large PAP subunit, AMV038,
functions alone to produce short poly(A) tails relative to the
length of those found in VACV. Our data also strongly suggests
that AMV038 does not dimerize with either AMV060 or
AMV115. Of the two small subunits, AMV060 can function as
a methyltransferase but is not essential for virus growth. The
function of AMV115 remains unknown, but the indications that
this gene is essential make it an interesting candidate for further
study.
Materials and methods
Cells and viruses
The Lymantria dispar cell line, Ld652, was maintained at
27 °C in SF900 II medium (Invitrogen) supplemented with 10%
heat treated FBS and 50 IU penicillin, 50 µg streptomycin per ml.
AMEVwas propagated in Ld652 cells grown in spinner flasks as
described previously (Becker et al., 2004). The virus was
collected from the supernatant and used directly for experiments,
or further purified over a cushion of 36% sucrose in 10 mM Tris,
pH8, at 42,874 ×g (18,000 rpm) for 80 min at 4 °C. Some
preparations were subsequently band purified over a 40–60%
sucrose step gradient, at 24,202 ×g for 40 min, 4 °C.BSC-40 cells, a continuous African green monkey kidney
cell line, were maintained in DMEM containing 10% FBS,
50 IU penicillin per ml and 50 µg streptomycin per ml. BSR-T7
cells were maintained in DMEM with 8% serum, and 50 IU
penicillin, 50 µg streptomycin per ml. G418 at 0.6 mg/ml was
added every other passage (Buchholz et al., 1999).
Protein purification
The genes encoding AMV060, AMV115 and AMV038 were
each cloned in framewith the 5′His-tag of the pET28b expression
vector (Novagen). The resulting plasmids were named p28-060,
p28-115, and p28-038. Protein expression of each of the plasmids
was examined in a number of E. coli expression strains. For
production of soluble AMV060 protein, E. coli strain BL21 DE3
Star (Invitrogen) containing p28-060 plasmid was grown in LB
broth, from an overnight culture, to an OD 600 of 0.7–0.8 and
protein expression was induced by the addition of IPTG to 1 mM.
Expressionwas allowed to proceed at 37 °C for 4 hwhile shaking.
The cells were pelleted by centrifugation at 6000 ×g for 15 min at
4 °C. The cell pellets wereweighed and frozen in a dry ice:ethanol
bath. After thawing the pellets on ice, they were resuspended at
3 ml per gram of pellet in binding buffer (20 mM Tris, pH7.5;
0.5MNaCl; 10mM imidazole). PMSFwas added to 0.2 mM and
followed by the addition of lysozyme to a final concentration of
0.1 mg/ml. The cell suspension was sonicated with a probe
sonicator 10 times for 30 s each, while on ice, resting between
bursts. DNase was then added to 5 µg/ml and the suspension
incubated at room temperature for 15 min with intermittent
vortexing. The resulting lysate was clarified by centrifugation at
18,000 ×g for 30 min. Prior to chromatography, the lysate was
filtered through a 0.45 µm filter. The clarified lysate was loaded
onto a 5 ml Ni2+ chelating column prepared according to the
manufacturer's instructions (HiTrap Chelating, GE). Purification
was performed on a Quad Tech Duo Flow system (Bio-Rad).
Buffers for chromatography were the binding buffer previously
described and an elution buffer of 20 mM Tris, pH7.5; 0.5 M
NaCl; 300 mM imidazole. After sample loading, the column was
washed with 3 column volumes (cv) of binding buffer and a 5cv
gradient of imidazole from 50 mM–125 mM. Proteins were
eluted from the column with an imidazole gradient of 125 mM–
250 mM for 2cv, followed by a 3cv elution in 300 mM imidazole.
The column was washed with 2cv of binding buffer. Fractions
were analyzed on duplicate SDS-PAGE gels which were either
stained with Coomassie Blue or used for immunoblotting with an
anti-His (Novagen) primary antibody as described previously
(Becker et al., 2004). Fractions identified as containing the His-
060 protein were combined and briefly dialyzed into 20 mMTris,
pH7. The protein was then further purified on a 6 ml Uno S-6
cation exchange column (Bio-Rad). The protein was loaded
in 20mMTris, pH7 (buffer 1) and the columnwashedwith 4cv of
the same buffer. This was followed by a 6cv gradient of 0–
300 mM NaCl in 20 mM Tris, pH7 and a steeper 4cv gradient of
300 mM NaCl to 1 M NaCl. Remaining protein was eluted from
the column with 4cv of 1 M NaCl and the column was washed
with 5cv 20 mM Tris, pH7. Fractions containing His-060 protein
were again identified by SDS-PAGE and immunoblotting.
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with a Centricon Plus-20 centrifugal concentrator (Millipore) by
centrifugation at 3200 ×g.
Purification of AMV115 was similar to that of AMV060
except that under no expression conditionswas significant soluble
protein obtained, although large amounts of insoluble protein
were produced. Insoluble His-115 protein was purified from E.
coli Rosetta pLysS cells (Novagen) containing the p28-115
plasmid. Protein expression from 3 L cultures of p28-115 in
Rosetta pLysS was induced with 1 mM IPTG for 4 h at 37 °C.
After pelleting the cells at 6000 ×g for 10 min, 4 °C, the pellets
were resuspended in 5 ml/g CelLytic II B (Sigma) lysis reagent
and frozen. Upon thawing, the lysates were treated with DNase at
5 µg/ml as described above. The lysate was then centrifuged for
5 min at 16,000 ×g, 4 °C. The pellets were then resuspended in
12ml of CelLytic and 0.2 mg/ml lysozyme and incubated at room
temperature for 5 min. The suspension was then diluted in 50 ml
of a 1:20 dilution of CelLytic II B and the inclusion bodies were
isolated at 16,000 ×g for 5min. The inclusion bodieswere washed
3 more times in diluted CelLytic II B. The final pellet was
resuspended in 3 ml 0.05M Tris, pH7.5; 0.15MNaCl (TBS) and
the proteins solubilized with 75 ml of 6 M guanidine hy-
drochloride; 20 mM Tris, pH 7.4; 50 mM imidazole. After
filtering through at 0.45 µm filter, the soluble protein was loaded
onto a 5 ml Ni2+ chelating column. The buffers for chromato-
graphywere a denaturing binding buffer of 6Murea; 20mMTris,
pH7.5; 0.5 M NaCl; 50 mM imidazole and a denaturing elution
buffer of 6 M urea; 20 mM Tris, pH7.5; 0.5 M NaCl; 500 mM
imidazole. After protein loading the columnwas washedwith 5cv
of denaturing binding buffer. Proteins were eluted from the
column by a 0–500 mM gradient of imidazole over 20cv. A final
elution of 5cv of 500mM imidazole denaturing elution buffer was
followed by a wash with 5cv of denaturing binding buffer. The
fractions were analyzed as described in the previous section for
the presence of His-115 protein. Fractions that contained the His-
115 protein were combined, concentrated as described above and
stored at −80 °C.
Methyltransferase assay
The methyltransferase assay was performed essentially as
described (Xiang et al., 2000). Purified His-060 (2 µg) was
incubated with 3H S-adenosylmethionine and 50 µg/ml brome
mosaic virus (BMV) genomic RNA. At 15 min intervals aliquots
of this mixture were spotted onto DE81 filters and allowed to dry.
The filters were washed in sodium phosphate and 3H incorpora-
tion was measured by scintillation counting. Purified His-tagged
VACV J3 protein served as a positive control (Xiang et al., 2000).
Antibody production
Antibodies to His-060 were generated by immunizing chic-
kens (Strategic Biosystems, SBS) with the purified soluble His-
060 protein described in the previous section. Total IgY was
purified by SBS and then tested by immunoblot against unin-
fected and AMEV infected cell lysates for specific antibodies.
His-060 purified protein was used as a control.Polyclonal mouse serum against His-060 was produced by
immunizing BalbC mice and standard techniques by the Uni-
versity of Florida Hybridoma Core. The mouse died unexpect-
edly prior to hybridoma formation.
Anti-peptide antibodies were produced in rabbits by Sigma-
Genosys. The peptides were synthesized and conjugated to
KLH then used to immunize two rabbits per peptide. The
peptides selected for each protein are as follows: AMV060—
DNPDDEPNTKNLINC located at aa142–155; for AMV115—
CMTLTFDEIESENY at aa216–228; and for the large subunit
AMV038— CVIDRYKIKGEHKEI at aa524–537. Serum from
rabbits was screened via immunoblots as described above. His-
060 and His-115 proteins were used as controls. One rabbit
immunized with the AMV060 peptide and one rabbit immunized
with the AMV115 peptide produced specific antibodies after 3
injections. After a final boost these rabbits were exsanguinated
and the serum affinity purified against the immunizing peptide.
Neither rabbit immunized against AMV038 produced specific
antibodies.
Deletion of AMV060 from AMEV
A DNA fragment containing AMV060 was amplified from
genomic AMEV with primers: IDT 172 5′-CGGGATCC-
TTTGCATCTACGTGTGGTAG-3′ containing a BamHI site
(underlined) and IDT 173 5′-GCCAAGCTTTTACAGTACA-
TTCGTCCATGA-3′ containing a HindIII site. After restriction
with BamHI and HindIII the fragment (2.725 kb) was ligated to
BamHI and HindIII digested pBS KS II+. A fragment
containing GFP and the spheroidin promoter was amplified
from pDU20 GFP with primers IDT 174 5′-CGGATATCGC-
CAATACATCATAA-3′ and IDT 175 5′-CTTGATATCGA-
ATTATCACTTGTACAGC-3′ both containing EcoRV sites
(Becker et al., 2004). This fragment was inserted into the
EcoRV sites internal to the AMV060 gene resulting in both a
deletion of 440 bp of DNAwithin the gene and the insertion of
the GFP marker. Recombinant viruses were isolated as pre-
viously described (Becker et al., 2004). Briefly, the plasmid
was transfected intoWTAMEVinfected cells and GFP positive
plaques were isolated and purified by 3–6 rounds of plaque
purification. The resulting virus is designated AMEVΔ060.
Time course of virus growth
Ld652 cells were seeded at 2×105 per well in 12 well dishes
for low MOI growth curves or at 3×105 per well for high MOI
growth curves. Cells were infected with sucrose band purified
wild type or AMEVΔ060 at an MOI=0.01 or 10 in duplicate.
Prior to infection, the virus was sonicated in a cup sonicator
twice for 1 min each. Virus was allowed to adsorb for a total of
3 h before removing and adding fresh medium. The low MOI
growth curve samples were harvested at 3, 12, 24, 48, 72, 96,
and 120 h post infection (hpi) and time points for the high MOI
growth curve were 3, 6, 12, 18, 24, 36, 48, and 72 hpi. For
harvesting, the cells were loosened from the surface of the dish
by pipetting and the virus, cells and medium were transferred to
a sterile 1.5 ml eppendorf. Virus was released from cells by
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assays as previously described (Becker et al., 2004).
Poly(A) tail length analysis
The length of mRNA poly(A) tails was performed as de-
scribed in Latner et al. (2002). Briefly, Ld652 cells were infected
with either WT or AMEVΔ060 at an MOI of 10. At various
times post infection, the cells were harvested and the RNA
isolated with Qiagen's RNeasy kit. VACV J3-7 virus is missing
the J3 protein due to a frameshift early in the gene (Latner et al.,
2000). J3-7 and WT VACV (WR strain) infected BSC40 cells
were processed in an identical manner to serve as controls.
Labeling of 1.5 µg RNAwas accomplished with 32P cytidine 3′
5′ bis(phosphate) and T4 RNA ligase for 18 h. RNA was
subsequently digested with 100 U RNase T1 and 2.5 U RNase A
for 4.5 h at 37 °C, followed by proteinase K digestion and
phenol:chloroform extraction. RNA was precipitated and sepa-
rated on an 8% polyacrylamide sequencing gel at a constant
power of 35 W. The Ambion Decade RNA ladder was used for
sizing. The gels were fixed with 10%methanol:10% acetic acid,
dried and developed on a storage phosphorimager screen. The
length of poly(A) tails was measured with a Storm phosphor-
imager (Molecular Dynamics).
Northern blot analysis
RNA samples were isolated from 1×106 Ld652 cells after
infection with WTAMEVat an MOI=10. For experiments with
cytosine arabinoside, (AraC), cells were infected at an MOI=10
for 3 h in either the presence of 250 μg/ml or the absence of
AraC. At 3 hpi, the virus was removed from the cells and 2 ml
fresh medium with or without 250 μg/ml AraC was added to the
cells. Infected cells were incubated at 27.5 °C. The preparation
of total RNA, the blotting procedure and the labeling of
antisense nucleotides for p4a and tkwere performed as described
previously (Becker et al., 2004). The antisense oligonucleotide
for detecting AMV115 was FS446 5′-GACAATCTCTCTAC-
GCTAATACACG-3′. A plasmid containing the entire AMV038
orf inserted into the pGEM4 vector (Promega) was used as the
template for a riboprobe. The plasmid, pGEM038, was digested
with NdeI which has 3 sites within the AMV038 orf, the closest
one to the SP6 promoter is about 500 bp. After ethanol
precipitation, labeled RNA was transcribed in the presence of
32P αCTP by SP6 RNA polymerase and the MaxiScript kit
(Ambion). All radioactive probes were purified with NucAway
spin columns (Ambion). Hybridization conditions for the
riboprobe were 60 °C overnight in Ultrahyb Buffer (Ambion).
Blots were then washed in 2× SSC; 0.1% SDS at room
temperature followed by a higher stringency wash in 0.1% SSC,
0.1% SDS at 68 °C.
Protein interactions via Alpha Screen and immunoprecipitation
studies
AMV060, AMV115, AMV038, VACV J3R and VACV E1L
were each cloned into the modified pTMI vectors: pTMI HA-FLAG (Dr. P.C. Turner, personal communication) and pTMI
FLAG (Moss et al., 1990; Turner and Moyer, 2006). For con-
structs in pTMI HA-FLAG, each gene was cloned in frame such
that the influenza HA tag was fused to the expressed protein and
a stop codon was inserted at the 3′ end of each gene so that the
FLAG tag was not expressed in these constructs. Genes ex-
pressed from pTMI FLAG have the FLAG tag fused to the
carboxy terminus of the protein. Proteins were expressed alone
or in combination from the T7 promoter of the plasmid after
transfection into the T7 RNA polymerase expressing cell line,
BSR-T7 (Buchholz et al., 1999). BSR-T7 cells in 6 well dishes
were transfected with 5 µg of each plasmid and 15 µl
Lipofectamine 2000 (Invitrogen) in 1 ml of OptiMEM medium
(Invitrogen). Transfections were performed at 37 °C overnight.
For metabolic labeling, the cells were washed and then starved
for 30 min in DMEM-Met, -Cys. At the end of the starvation,
50 µCi Tran35 S-Label (MP Biomedical) was added and
labeling continued for 2 h at 37 °C. Radiolabeled cells were
harvested by scraping and then pelleted by centrifugation at
3000 ×g for 1 min. The cell pellet was washed in 1 ml PBS and
centrifuged again. This pellet was resuspended in 100 µl of lysis
buffer (100 mM Tris, pH 8; 100 mMNaCl, 0.5% NP40, 0.2 mM
PMSF) and incubated on ice for 5 min. Insoluble proteins were
removed by centrifugation at 13,000 ×g for 10 min at 4 °C and
the supernatant was used for immunoprecipitations.
For co-immunoprecipitations, 40 µl of extract prepared as
described above, was pre-incubated with 12 µl of a 50% slurry
of protein A sepharose (GE) for 1 h at 4 °C. After centrifugation
at 11,000 ×g for 30 s, the supernatant was transferred to a new
tube and 100 µl of lysis buffer was added plus either 0.5 µg of
rat monoclonal anti-HA antibody (Roche) or 5 µg monoclonal
anti-FLAG antibody (Sigma). After an overnight incubation at
4 °C with continuous rotation, 30 µl protein A sepharose was
added to the mixture and incubated with rotation for a further
1 h at 4 °C. The protein A sepharose and bound antibody:
antigen complex were pelleted at 11,000 ×g for 30 s and then
washed 3 times with 1 ml of lysis buffer. The pellet was re-
suspended in 10 µl of SDS-PAGE loading buffer and heated to
95 °C prior to analysis by 10% SDS-PAGE. Gels were fixed in
25% methanol:7% acetic acid then incubated for 1 h in Amplify
(GE) to increase signal intensity prior to drying and exposure to
X-ray film.
For Amplified Luminescent Proximity Homogeneous Assay
(AlphaScreen, Perkin Elmer) analysis, 2 µl of protein extract
prepared abovewas diluted 1 /10 in 1mg/ml BSA in PBS per well
of a 386 well white dish, followed by the addition of 12.5 µg of
biotinylated rat monoclonal anti-HA antibody (Roche) and 0.5 ng
Anti-FLAG (M2) acceptor beads (Perkin Elmer). Samples were
assayed in duplicate. After a 1.5 h incubation at room temperature
in the dark, 0.5 µg of streptavidin donor beads was added.
Incubation continued at room temperature in the dark for 1.5 h.
Light emission was analyzed on an EnVision plate reader.
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